"Patient focused. Data driven. I’m inspired by the impact we can make in patient’s lives and love when I am able to contribute to a team through quantitative data analysis, creative problem-solving, and scientific logic/rationale."
I joined the Clinical Pharmacology Department at Genentech in 2016, where I have focused on supporting ophthalmology programs. I work on cross-functional teams that support the clinical development of new drug candidates. I love seeing how all the pieces come together to inform team decisions and move a program forward.
Prior to Genentech, I received my PhD in chemical engineering at MIT, where I conducted research as a Hertz fellow in Dane Wittrup’s lab at the Koch Institute for Integrative Cancer Research. My graduate research focused on the cellular level processing of antibody-drug conjugates, as a targeted cancer therapy. I developed a quantitative model of antibody-drug conjugates processing in order to understand what are the rate limiting steps for drug delivery via an antibody-drug conjugate.
My focus is on clinical drug development, specifically on clinical pharmacology, which includes understanding the pharmacokinetics and pharmacodynamics of a drug in humans and how these and other factors relate to the clinical efficacy and safety of the drug. I support clinical study designs, regulatory documentation and interactions, clinical study data analysis and interpretation, and project team decision making. I collaborate with a number of other functions including preclinical and translational PK/PD, regulatory, biostatistics, clinical science, clinical operations, biomarkers, technical development, bioanalytical sciences, safety assessment, and many more.